EP1693469B1 - Detecting DNA sequence variations - Google Patents
Detecting DNA sequence variations Download PDFInfo
- Publication number
- EP1693469B1 EP1693469B1 EP06076004A EP06076004A EP1693469B1 EP 1693469 B1 EP1693469 B1 EP 1693469B1 EP 06076004 A EP06076004 A EP 06076004A EP 06076004 A EP06076004 A EP 06076004A EP 1693469 B1 EP1693469 B1 EP 1693469B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- target
- nucleotide
- dna
- oligonucleotides
- probes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6862—Ligase chain reaction [LCR]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00608—DNA chips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/0061—The surface being organic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00623—Immobilisation or binding
- B01J2219/00626—Covalent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/179—Nucleic acid detection characterized by the use of physical, structural and functional properties the label being a nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Definitions
- DNA sequences forms the basis of many applications in modern genetic analysis: it is used in linkage analysis to track disease genes in human pedigrees or economically important traits in animal and plant breeding programmes; it forms the basis of fingerprinting methods used in forensic and paternity testing [Krawczak and Schmidtke, 1994]; it is used to discover mutations in biologically and clinically important genes [Cooper and Krawczak, 1989].
- the importance of DNA polymorphism is underlined by the large number of methods that have been developed to detect and measure it [Cotton, 1993]. Most of these methods depend on one of two analytical procedures, gel electrophoresis or molecular reassociation, to detect sequence variation. Each of these powerful procedures has its drawbacks.
- Gel electrophoresis has very high resolving power, and is especially useful for the detection of variation In the mini- and microsatellite markers that are used in linkage analysis and fingerprinting: it is also the method used to analyse the variation found in the triplet repeats that cause a number of mutations now known to be the cause of around ten genetic disorders in humans [Willems, 1994].
- gel electrophoresis has proved difficult to automate: even the systems which automate data collection require manual gel preparation; and as samples are loaded by hand, it is easy to confuse samples.
- the continuous reading electrophoresis machines are expensive, and manual analysis is technically demanding, so that its use is confined to specialised laboratories which have a high throughput. Furthermore, difficulties in measuring fragment size preclude rigorous statistical analysis of the results.
- oligonucleotide hybridisation lends itself to automation and to quantitative analysis [Southern et al ., 1992], but it is not well suited to the analysis of variation in the number of repeats in the micro- and minisatellites, as the small fractional change in the number of repeats produces a barely detectable change in signal strength; and of course it would not be possible to distinguish two alleles in the same sample as each would contribute to a single intensity measurement. Thus, many different combinations of alleles would produce the same signal.
- the invention describes a general approach which can be applied to all forms of variation commonly used as DNA markers for genetic analysis. It combines sequence-specific hybridisation to oligonucleotides, which are tethered to an array of individual beads, with enzymatic reactions which enhance the discrimination between matching and non-matching duplexes, and at the same time provide a way of attaching a label to indicate when or which reaction has taken place, chain extension by DNA dependent DNA polymerases is dependent on perfect matching of sequences at or around the point of extension or joining. As we shall show, there are several ways in which these enzymes can be used with sequence-specific oligonucleotides to detect variation in target sequences.
- the sequence to be analysed will be available as a nucleic acid molecule, and may be a DNA molecule produced, for example, by the polymerase chain reaction.
- the methods are not confined to analysis of DNA produced in this way.
- the target sequence is first captured by hybridisation to oligonucleotides which are tethered to individual beads; for example, the oligonucleotides may be synthesised in situ as described [Maskos and Southern, 1992]; or they may be presynthesised and then coupled to the surface [Khrapko et al . 1991] .
- the novelty arises from the exploitation of enzymes in combination with substrates or primers tethered to individual heads.
- the invention provides a method of analysis which comprises: providing a polynucleotide target including a nucleotide at a specified position, and an array of oligonucleotide probes, tethered to a individual beads, said probe being complementary to the target and terminating are base before the said specified position; and performing the steps:
- a polynucleotide target is provides, in solution when the probe is tethered to a support, and may be DNA or RNA. This polynucleotide target is caused to hybridise with an oligonucleotide probe.
- oligonucleotide is used here, as common terminology for the primers and substrates commonly utilised by polymerase and ligase enzymes. However, the term is used in a broad sense to cover any substance that serves as a substrate for the enzymes, including single stranded chains of short or moderate length composed of the residues of nucleotides or of nucleotide analogues, and also longer chains that would ordinarily be referred to as polynucleotides.
- the probes may be tethered to individual beads preferably by a covalent linkage and preferably through a 5' or 3'terminal nucleotide residue.
- An array of oligonucleotide probes are tethered at spaced locations, on individual beads.
- each component oligonucleotide i) comprises a sequence complementary to the target including an expected variant of the target, and ii) is tethered to an individual bead in a chemical orientation which a) permits duplex formation with the target, and b) permits chain extension only when the sequence of the oligonucleotide matches the variable sequence of the target.
- an array of oligonucleotides in which different oligonucleotides occupy different individual beads and each oligonucleotide has a 3' nucleotide residue through which it is covalently tethered to a support and a 5' nucleotide residue which is phosphorylated.
- the tethered oligonucleotide terminates at a position one base before the variable base in the target sequence ( Fig.1 ).
- a nucleotide precursor triphosphate or dideoxyribonucleotide triphosphate labelled, for example with a fluorescent tag, is added in the presence of a nucleic acid synthesising enzyme which requires a specific template in order to incorporate the complementary base.
- the labelled base will be incorporated from a deoxyribonucleotide precursor only if the precursor base is complementary to the base in the target sequence. Thus, mutants will give a negative result.
- the tethered oligonucleotide terminates in a base which is complementary to the variable base in the target sequence.
- Labelled precursor nucleoside triphosphates and polymerase are added. Polymerisation takes place only if the last base of the primer is complementary to the variable base in the target ( Fig.2 ). Thus, mutants will give a negative result.
- DNA polymerases reverse transcriptases
- some DNA dependent RNA polymerases can use as substrates one or more oligonucleotides which are bound to a long DNA strand through Watson-Crick base pairing.
- an oligonucleotide is used as a primer to which the first base in the growing chain is added. It is this property that makes the enzyme useful for the detection of DNA sequence variation; in particular, the requirement for specific base pairing at the site of extension complements the sequence discrimination that is already provided by the Watson-Crick pairing between the oligonucleotide and the target sequence that is needed to form a stable duplex.
- the invention described here employs an array of oligonucleotides coupled individual beads, so that the advantages of working in mixed phase are brought to all steps: hybridisation, enzymatic extension or joining, and detection. This provides great sensitivity and convenience. This enables many different sequences to be analysed together, in a single reaction; this also ensures that all reactions are carried out under identical conditions, making comparisons more reliable.
- oligonucleotides bound to individual beads Two different methods have been developed for making oligonucleotides bound to individual beads; they can be synthesised in situ, or presynthesised and attached to the bead. In either case, it is possible to use the support-bound oligonucleotides in a hybridisation reaction with orgonucleotides in the liquid phase to form duplexes; the excess of oligonucleotide in solution can then be washed away. Hybridisation can be carried out under stringent conditions, so that only well-matched duplexes are stable. When enzymes are to be used, the chemical orientation of the oligonucleotide is important: polymerases add bases to the 3' end of the chain.
- Oligonucleotides tethered to the beads through either end can be made in situ by using the appropriate phospharamidite precursors [references in Beaucage and lyer, 1992]; or presynthesised oligonucleotides can be fixed through appropriate groups at either end.
- oligonucleotides can be phosphorylated at the 5' end in situ using ATP and polynucleotide kinase, or they may be phosphorylated chemically [Horn and Urdea, 1986].
- oligonucleotides tethered to the solid substrate can take part in reactions catalysed by DNA polymerases.
- the M13 sequencing primer-5'-GTAAAACGACGGCCAGT-3' - attached to aminated polypropylene through its 5' end was synthesised as described.
- a solution of M13 DNA (single-strand, replicative form, 0.1 ⁇ l, 200 ng/ ⁇ l) was applied in two small spots to the surface of the derivatised polypropylene.
- the polypropylene was incubated at 37°C for 1 hr in a vapour saturated chamber. It was then washed in 1% SDS at 100°C for one minute, and exposed to a storage phosphor screen for one minute and scanned in a phosphorimager. The regions where the DNA had been applied showed a high level of radioactivity, against a low background where no DNA had been applied.
- This experiment shows that oligonucleotides tethered to a solid support can act as primers for DNA-dependent synthesis by DNA polymerase, as required for applications using this enzyme for mutation detection.
- oligonucleotide arrays of ASOs could be used to create oligonucleotide arrays of ASOs, but in order that they can be used as substrates for the enzymes, they need to be modified; for extension by polymerase it will be necessary to attach to oligonucleotides to the solid substrate by their 5' ends.
- a strip of the array (30mm x 2mm) from Example 2 was added to a solution of 200 pmols of the target oligonucleotide 5' cacagactccatgg(tgaa) 6 tgagggaaataag, 200 pmol of oligo 5' ccatggagtctgtg (chemically phosphorylated at the 5' end) with buffer and salts according to the suppliers instructions, the total volume being 243 ⁇ l.
- the solution was heated to 65°C and cooled to 37°C over a period of 30 mins. 7 ⁇ l of Tth DNA ligase was added and the reaction mixture heated at 34°C for 17hrs.
- the strip was removed and added to a solution of 8 mM DTT, 3.3 pmol 32 P alpha dTTP, 13 units sequenase version 2.0 and buffer and salts according to the suppliers instructions. The total volume was 250 ⁇ l. After heating at 37°C for 3 hrs the strip was removed from the reaction solution, washed in TE buffer, blotted dry and exposed to a storage phosphor screen from which an image of the radioactivity was taken. The results showed counts equal to background over the area of the array where repeats were equal in length or greater than the repeat length of the target, with 20 times the signal in the areas where the repeat length of the array was shorter than the repeat length in the target.
- reporter nucleotides were chosen, in one case to identify the correct repeat length, and in the other case to identify shorter repeat lengths. This is made possible when the repeat sequence comprises less than all four bases.
- a base is chosen which is present in the repeat sequence and is different from the first base in the flanking sequence.
- a base is chosen to be complementary to the first base in the flanking sequence which is absent from the repeat.
- a strip of the array from Example 2 (30mm x 2mm) was added to a solution of 500 pmols of the target oligonucleotide 5' cacagactccatgg(tgaa) 6 tgagggaaataag in buffer and salts at a concentration 1.09 times the suppliers instructions, the total volume being 275 ⁇ l.
- the solution was heated to 75°C for 5 minutes and cooled to 37°C over a period of 25mins.
- the solution was removed and added to 3.3 pmols 32 P alpha dCTP, 5 ⁇ l 1M DTT. 13 units of Sequenase version 2.0 and water to give a final volume of 295 ⁇ l.
- a similar strip of the array (30mm x 2mm) was added to a solution of 500 pmols of the target oligonucleotide 5' cacagactccatgg(tgaa) 6 tgagggaaataag in buffer and salts 1.09 times the suppliers instructions, the total volume being 275 ⁇ l.
- the solution was heated to 75°C for 5 mins and cooled to 37°C over a period of 25 mins.
- the solution was removed and added to 3.3 pmols 32 P alpha dTTP, 5 ⁇ l 1M DTT, 13 units of Sequenase version 2.0 and water to give a final volume of 295 ⁇ l.
- This solution was added to the array and heated at 37°C for 15hrs 40mins.
- the polypropylene strip was removed, washed In water and exposed to a storage phosphor screen. The results showed counts of 4.5 times more for the shorter array sequences than the correct and longer repeat lengths.
Description
- Detection of variation in DNA sequences forms the basis of many applications in modern genetic analysis: it is used in linkage analysis to track disease genes in human pedigrees or economically important traits in animal and plant breeding programmes; it forms the basis of fingerprinting methods used in forensic and paternity testing [Krawczak and Schmidtke, 1994]; it is used to discover mutations in biologically and clinically important genes [Cooper and Krawczak, 1989]. The importance of DNA polymorphism is underlined by the large number of methods that have been developed to detect and measure it [Cotton, 1993]. Most of these methods depend on one of two analytical procedures, gel electrophoresis or molecular reassociation, to detect sequence variation. Each of these powerful procedures has its drawbacks. Gel electrophoresis has very high resolving power, and is especially useful for the detection of variation In the mini- and microsatellite markers that are used in linkage analysis and fingerprinting: it is also the method used to analyse the variation found in the triplet repeats that cause a number of mutations now known to be the cause of around ten genetic disorders in humans [Willems, 1994]. Despite its great success and widespread use, gel electrophoresis has proved difficult to automate: even the systems which automate data collection require manual gel preparation; and as samples are loaded by hand, it is easy to confuse samples. The continuous reading electrophoresis machines are expensive, and manual analysis is technically demanding, so that its use is confined to specialised laboratories which have a high throughput. Furthermore, difficulties in measuring fragment size preclude rigorous statistical analysis of the results.
- By contrast, oligonucleotide hybridisation lends itself to automation and to quantitative analysis [Southern et al., 1992], but it is not well suited to the analysis of variation in the number of repeats in the micro- and minisatellites, as the small fractional change in the number of repeats produces a barely detectable change in signal strength; and of course it would not be possible to distinguish two alleles in the same sample as each would contribute to a single intensity measurement. Thus, many different combinations of alleles would produce the same signal. Present hybridisation methods are much better suited to analysing variation in the DNA due to point mutation - base substitution deletions and insertions, for which it is possible to design allele specific oligonucleotides (ASOs) that recognise both the wild type and the mutant sequences [Conner et al., 1983]. Thus it is possible in principle, In a relatively simple test, to detect all possible genotypes. However, a problem that arises in practice in the use of oligonucleotide hybridisation is that in some cases the extent of reassociation is barely affected by a mismatched base pair.
- The invention describes a general approach which can be applied to all forms of variation commonly used as DNA markers for genetic analysis. It combines sequence-specific hybridisation to oligonucleotides, which are tethered to an array of individual beads, with enzymatic reactions which enhance the discrimination between matching and non-matching duplexes, and at the same time provide a way of attaching a label to indicate when or which reaction has taken place, chain extension by DNA dependent DNA polymerases is dependent on perfect matching of sequences at or around the point of extension or joining. As we shall show, there are several ways in which these enzymes can be used with sequence-specific oligonucleotides to detect variation in target sequences.
- In all cases, the sequence to be analysed, the target sequence, will be available as a nucleic acid molecule, and may be a DNA molecule produced, for example, by the polymerase chain reaction. However, the methods are not confined to analysis of DNA produced in this way. The target sequence is first captured by hybridisation to oligonucleotides which are tethered to individual beads; for example, the oligonucleotides may be synthesised in situ as described [Maskos and Southern, 1992]; or they may be presynthesised and then coupled to the surface [Khrapko et al. 1991].
- In one aspect of the invention the novelty arises from the exploitation of enzymes in combination with substrates or primers tethered to individual heads.
- In one aspect the invention provides a method of analysis which comprises: providing a polynucleotide target including a nucleotide at a specified position, and an array of oligonucleotide probes, tethered to a individual beads, said probe being complementary to the target and terminating are base before the said specified position; and performing the steps:
- a) incubating the target with the probe to form a duplex,
- b) incubating the duplex under chain extension conditions with at least one labelled nucleotide,
- c) and monitoring chain extension in b) as an indication of the nucleotide at the specified position in the target.
- A polynucleotide target is provides, in solution when the probe is tethered to a support, and may be DNA or RNA. This polynucleotide target is caused to hybridise with an oligonucleotide probe. The term oligonucleotide is used here, as common terminology for the primers and substrates commonly utilised by polymerase and ligase enzymes. However, the term is used in a broad sense to cover any substance that serves as a substrate for the enzymes, including single stranded chains of short or moderate length composed of the residues of nucleotides or of nucleotide analogues, and also longer chains that would ordinarily be referred to as polynucleotides.
- The probes may be tethered to individual beads preferably by a covalent linkage and preferably through a 5' or 3'terminal nucleotide residue. An array of oligonucleotide probes are tethered at spaced locations, on individual beads.
- In another aspect there is described an array of oligonucleotides, for analysing a polynucleotide target containing a variable sequence, in which each component oligonucleotide i) comprises a sequence complementary to the target including an expected variant of the target, and ii) is tethered to an individual bead in a chemical orientation which a) permits duplex formation with the target, and b) permits chain extension only when the sequence of the oligonucleotide matches the variable sequence of the target.
- In another aspect there is described an array of oligonucleotides in which different oligonucleotides occupy different individual beads and each oligonucleotide has a 3' nucleotide residue through which it is covalently tethered to a support and a 5' nucleotide residue which is phosphorylated.
- Reference is directed to the accompanying drawings in which each of
Figures 1 to 6 is a series of diagrams illustrating a method according to the invention. -
Figure 1 shows detection of point mutation by single base extension. -
Figure 2 shows detection of point mutation by hybridisation to allele specific oligonucleotides and chain extension. - In this application, the tethered oligonucleotide terminates at a position one base before the variable base in the target sequence (
Fig.1 ). A nucleotide precursor triphosphate or dideoxyribonucleotide triphosphate, labelled, for example with a fluorescent tag, is added in the presence of a nucleic acid synthesising enzyme which requires a specific template in order to incorporate the complementary base. In the case of DNA polymerase, the labelled base will be incorporated from a deoxyribonucleotide precursor only if the precursor base is complementary to the base in the target sequence. Thus, mutants will give a negative result. - In this case, the tethered oligonucleotide terminates in a base which is complementary to the variable base in the target sequence. Labelled precursor nucleoside triphosphates and polymerase are added. Polymerisation takes place only if the last base of the primer is complementary to the variable base in the target (
Fig.2 ). Thus, mutants will give a negative result. - Most DNA polymerases, reverse transcriptases, some DNA dependent RNA polymerases can use as substrates one or more oligonucleotides which are bound to a long DNA strand through Watson-Crick base pairing. In the case of polymerases, an oligonucleotide is used as a primer to which the first base in the growing chain is added. It is this property that makes the enzyme useful for the detection of DNA sequence variation; in particular, the requirement for specific base pairing at the site of extension complements the sequence discrimination that is already provided by the Watson-Crick pairing between the oligonucleotide and the target sequence that is needed to form a stable duplex. Thus, it has been found that discrimination by hybridisation alone is most sensitive if the variant base(s) is (are) close to the middle of the oligonucleotide. By contrast, for the enzymes, discrimination is highest if the variant mismatching bases are close to the end where the extension or join takes place. Together, hybridisation under stringent conditions and enzymatic extension provide greater discrimination than either alone, and several methods have been developed to exploit this combination in systems for genetic analysis [references in cotton, 1993].
- The invention described here employs an array of oligonucleotides coupled individual beads, so that the advantages of working in mixed phase are brought to all steps: hybridisation, enzymatic extension or joining, and detection. This provides great sensitivity and convenience. This enables many different sequences to be analysed together, in a single reaction; this also ensures that all reactions are carried out under identical conditions, making comparisons more reliable.
- Two different methods have been developed for making oligonucleotides bound to individual beads; they can be synthesised in situ, or presynthesised and attached to the bead. In either case, it is possible to use the support-bound oligonucleotides in a hybridisation reaction with orgonucleotides in the liquid phase to form duplexes; the excess of oligonucleotide in solution can then be washed away. Hybridisation can be carried out under stringent conditions, so that only well-matched duplexes are stable. When enzymes are to be used, the chemical orientation of the oligonucleotide is important: polymerases add bases to the 3' end of the chain. Oligonucleotides tethered to the beads through either end can be made in situ by using the appropriate phospharamidite precursors [references in Beaucage and lyer, 1992]; or presynthesised oligonucleotides can be fixed through appropriate groups at either end. We will demonstrate that oligonucleotides can be phosphorylated at the 5' end in situ using ATP and polynucleotide kinase, or they may be phosphorylated chemically [Horn and Urdea, 1986].
- The applications envisaged here require that the oligonucleotides tethered to the solid substrate can take part in reactions catalysed by DNA polymerases.
- The M13 sequencing primer-5'-GTAAAACGACGGCCAGT-3' - attached to aminated polypropylene through its 5' end was synthesised as described. A solution of M13 DNA (single-strand, replicative form, 0.1 µl, 200 ng/µl) was applied in two small spots to the surface of the derivatised polypropylene. A solution containing three non-radioactive deoxyribonucleotide triphosphates, dATP, dGTP, TTP (10 µmol each), α32P-dCTP (10 µCl), Taq DNA polymerase and appropriate salts, was applied over a large area of the polypropylene, including the area where the M13 DNA had been spotted. The polypropylene was incubated at 37°C for 1 hr in a vapour saturated chamber. It was then washed in 1% SDS at 100°C for one minute, and exposed to a storage phosphor screen for one minute and scanned in a phosphorimager. The regions where the DNA had been applied showed a high level of radioactivity, against a low background where no DNA had been applied. This experiment shows that oligonucleotides tethered to a solid support can act as primers for DNA-dependent synthesis by DNA polymerase, as required for applications using this enzyme for mutation detection.
- Experiments described below show that both polynucleotide kinase and DNA ligase can be used to modify oligonucleotides tethered to a solid support. There are several ways in which phosphorylated oligonucleotides and the ligase reaction can be used to detect sequence variation.
- It will be necessary to use an array of oligonucleotides tethered to a individual beads for example, glass spheres, or magnetic beads. In this case the reactions could be carried out in tubes, or in the wells of a microtitre plate. Methods for both synthesising oligonucleotides and for attaching presynthesised oligonucleotides to these materials are known [Stahl et al., 1988]. Methods for making arrays of ASO's representing point mutations were described In patent application
WO89/0977 and in Maskos and Southern 1993 - For the present invention, the same methods could be used to create oligonucleotide arrays of ASOs, but in order that they can be used as substrates for the enzymes, they need to be modified; for extension by polymerase it will be necessary to attach to oligonucleotides to the solid substrate by their 5' ends.
- It is often desirable to scan a relatively short region of a gene or genome for point mutations: for example, many different sites are mutated in the CFTR gene to give rise to cystic fibrosis: similarly, the p53 tumour suppressor gene can be mutated at many sites. The large numbers of oligonucleotides needed to examine all potential sites in the sequence can be made by efficient combinatorial methods [Southern et al., 1994]. A modification of the protocol could allow such arrays to be used in conjunction with enzymes to look for mutations at all sites in the target sequence.
- A strip of the array (30mm x 2mm) from Example 2 was added to a solution of 200 pmols of the target oligonucleotide 5' cacagactccatgg(tgaa)6tgagggaaataag, 200 pmol of oligo 5' ccatggagtctgtg (chemically phosphorylated at the 5' end) with buffer and salts according to the suppliers instructions, the total volume being 243 µl. The solution was heated to 65°C and cooled to 37°C over a period of 30 mins. 7 µl of Tth DNA ligase was added and the reaction mixture heated at 34°C for 17hrs. The strip was removed and added to a solution of 8 mM DTT, 3.3 pmol 32P alpha dTTP, 13 units sequenase version 2.0 and buffer and salts according to the suppliers instructions. The total volume was 250 µl. After heating at 37°C for 3 hrs the strip was removed from the reaction solution, washed in TE buffer, blotted dry and exposed to a storage phosphor screen from which an image of the radioactivity was taken. The results showed counts equal to background over the area of the array where repeats were equal in length or greater than the repeat length of the target, with 20 times the signal in the areas where the repeat length of the array was shorter than the repeat length in the target.
- Two types of polymerase analysis were carried out where reporter nucleotides were chosen, in one case to identify the correct repeat length, and in the other case to identify shorter repeat lengths. This is made possible when the repeat sequence comprises less than all four bases.
- In the former case a base is chosen which is present in the repeat sequence and is different from the first base in the flanking sequence. In the latter case a base is chosen to be complementary to the first base in the flanking sequence which is absent from the repeat.
- A strip of the array from Example 2 (30mm x 2mm) was added to a solution of 500 pmols of the target oligonucleotide 5' cacagactccatgg(tgaa)6tgagggaaataag in buffer and salts at a concentration 1.09 times the suppliers instructions, the total volume being 275 µl. The solution was heated to 75°C for 5 minutes and cooled to 37°C over a period of 25mins. The solution was removed and added to 3.3 pmols 32P alpha dCTP, 5 µl 1M DTT. 13 units of Sequenase version 2.0 and water to give a final volume of 295 µl. This solution was added to the array and heated at 37°C for 15hrs 40mins. The polypropylene strip was removed, washed in water and exposed to a storage phosphor screen. The results showed counts of 5 times more for the correct sequence than shorter sequences and twice for the correct sequence compared with longer repeats.
- A similar strip of the array (30mm x 2mm) was added to a solution of 500 pmols of the target oligonucleotide 5' cacagactccatgg(tgaa)6tgagggaaataag in buffer and salts 1.09 times the suppliers instructions, the total volume being 275 µl. The solution was heated to 75°C for 5 mins and cooled to 37°C over a period of 25 mins. The solution was removed and added to 3.3 pmols 32P alpha dTTP, 5 µl 1M DTT, 13 units of Sequenase version 2.0 and water to give a final volume of 295 µl. This solution was added to the array and heated at 37°C for 15hrs 40mins. The polypropylene strip was removed, washed In water and exposed to a storage phosphor screen. The results showed counts of 4.5 times more for the shorter array sequences than the correct and longer repeat lengths.
-
- 1. Beaucage, S. L. and lyer, R. P. (1992). Advances in the synthesis of oligonucleotides by the phosphoramidite approach. Tetrahedron 48: 2223-2311.
- 2. Conner, B. J., Reyes, A. A., Morin, C., Itakura, K., Teplitz, R. L., and Wallace, R. B. (1983). Detection of sickle cell β' globin allele by hybridization with synthetic oligonucleotides. Proc. Natl. Acad. Sci. USA 80: 278-282.
- 3. Cooper, D. N., and Krawczak, M. (1989). The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions. Hum. Genet. 85: 55-74.
- 4. Cotton, RG, (1993) Current methods of mutation detection. Mutation Research 285: 125-144.
- 5. Horn, T., and Urdea, M. (1986) Chemical phosphorylation of oligonucleotides. Tetrahedron Letters 27: 4705.
- 6. Khrapko, K. R., Lysov, Yu. P., Khorlyn, A. A., Shick, V. V., Florentiev, V. L., and Mirzabekov. (1989). An oligonucleotide hybridization approach to DNA sequencing. FEBS Lett. 256: 118-122.
- 7. Krawczak M. and Schmidtke, J. (1994). DNA fingerprinting. BIOS Scientific Publishers.
- 8. Maskos, U., and Southern, E.M., (1993) A novel method for the analysis of multiple sequence variants by hybridisation to oligonucleotides. Nucleic Acids Research, 21: 2267-2268.
- 9. Pillai, V. N. R.(1980). Photoremovable protecting groups in organic chemistry Synthesis 39: 1-26.
- 10. Southern, E. M. (1988). Analyzing Polynucleotide Sequences. International Patent Application
PCT/GB89/00460 - 11. Southern, E.M., Maskos, U. and Elder, J.K. (1992). Analysis of Nucleic Acid Sequences by Hybridization to Arrays of Oligonucleotides: Evaluation using Experimental Models. Genomics 12: 1008-1017.
- 12. Southern. E. M., Case-Green, Elder, J.K. Johnson, M., Mir, K.U., Wang, L., and Williams, J.C. (1994). Arrays of complementary oligonucleotides for analysing the hybridisation behaviour of nucleic acids. Nucleic Acids Res. 22:, 1368-1373.
- 13. Stahl, S., Hultman, T., Olsson, A., Moks, T.D and, Uhlen, M. (1988) Solid phase DNA sequencing using the biotin-avidin system. Nucleic Acids Res. 16: 3025-38.
- 14. Veerle, A.M.C.S., Moerkerk, P.T.M.M., Murtagh, J.J., Jr., Thunnissen, F.B.J.M (1994) A rapid reliable method for detection of known point mutations: Point-EXACCT. Nucleic Acids Research 22: 4840-4841.
- 15. Vimekas, B., Liring, G., Pluckthon, K., Schneider, C., Wellhofer, G. and Moroney, S. E. (1994) Trinucleotide phosphoramidites: ideal reagents for the synthesis of mixed oligonucleotides for random mutagenesis. Nucleic Acids Research 22: 5600-5607.
- 16. Willems, P.J. (1994) Dynamic mutations hit double figures. Nature Genetics 8: 213-216.
-
Condition Repeat Normal Preexpansion Expanded Reference FRAXA CGG/CCG 10-50 38-50 200-1000 Verkerk et al. 1991 FRAXE CGG/CCG 200-1000 Knight et al. 1993 FRAXF GCC/CGG 6-18 ? 300-500 Parrish et al. 1994 FRAX16A CGG/CCG 1000-2000 Nancarrow et al. 1994 SBMA CAG 11-31 ? 40-62 Tilley et al. 1994 Huntington CAG 11-34 30-34 42-100 Huntington group 1993 SCA1 CAG 25-36 ? 43-81 Orr et al. 1993 DRPLA/HRS CAG ≤100 Burke et al. 1994 Machado-Joseph CAG/CTG ∼26 ? 68-79 Kawaguchi et al. 1994 -
- <110> OXFORD GENE TECHNOLOGY IP LIMITED
- <120> DETECTING DNA SEQUENCE VARIATIONS
- <130> P043743EP
- <150>
GB-9507238.5
<151>1995-04-07 - <160> 9
- <170> SeqWin99, version 1.02
- <210> 1
<211> 17
<212> DNA
<213> Artificial Sequence - <220>
<223> M13 sequencing primer - <400> 1
gtaaaacgac ggccagt 17 - <210> 2
<211> 20
<212> DNA
<213> Artificial Sequence - <220>
<223> Anchor sequence - <400> 2
tgtagtggtg tgatcaaggc 20 - <210> 3
<211> 21
<212> DNA
<213> Artificial Sequence - <220>
<223> Tag - <400> 3
gtggtcacta aagtttctgc t 21 - <210> 4
<211> 13
<212> DNA
<213> Artificial Sequence - <220>
<223> Anchoring sequence - <400> 4
cttatttccc tca 13 - <210> 5
<211> 51
<212> DNA
<213> Artificial Sequence - <220>
<223> Target oligonucleotide - <400> 5
cacagactcc atggtgaatg aatgaatgaa tgaatgaatg agggaaataa g 51 - <210> 6
<211> 14
<212> DNA
<213> Artificial Sequence - <220>
<223> Oligo - <400> 6
ccatggagtc tgtg 14 - <210> 7
<211> 32
<212> DNA
<213> Artificial Sequence - <220>
<223> Anchor sequence - <400> 7
agagatgtag tctcattctt tcgccaggct gg 32 - <210> 8
<211> 27
<212> DNA
<213> Artificial Sequence - <220>
<223> Template oligonucleotide - <400> 8
tcgttttacc gtcatgcgtc ctctctc 27 - <210> 9
<211> 29
<212> DNA
<213> Artificial Sequence - <220>
<223> Target oligonucleotide - <400> 9
tcctctctcc gtcatgcgta tcgttcaat 29
Claims (13)
- A method of analysis which comprises; providing a polynucleotide target including a nucleotide at a specified position, and an array of oligonucleotide probes, tethered to individual beads, wherein a probe in said array is complementary to the target and terminates one base before the said specified position; and performing the steps:a) incubating the target with the probes to form a duplex,b) incubating the duplex under chain extension conditions with at least one labelled nucleotide ; andc) monitoring chain extension in b) as an indication of the nucleotide at the specified position in the target.
- The method of claim 1, wherein different labelled nucleotides used in step (b) are labelled differently.
- The method of claim 1, wherein the labelled nucleotide used in step (b) is a deoxyribonucleotide triphosphate, a dideoxyribonucleotide triphosphate or a nucleotide precursor triphosphate.
- The method of any one of claims 1 - 3, wherein a nucleotide used in step (b) is labelled with fluorescent tag.
- The method of any one of claims 1 - 4, wherein step (b) involves single base-specific extension.
- The method of any one of claims 1 - 4, wherein the oligonucleotide probes are attached to the beads by their 5'ends.
- The method of any one of claims 1 - 4, wherein the probes are tethered by a covalent linkage.
- The method of any one of claims 1 - 4, wherein an enzyme is used in step (b).
- The method of claim 8, wherein an enzyme is a polymerase.
- The method of claim 8, wherein the enzyme is a DNA polymerase, a reverse transcriptase, or a RNA polymerase.
- The method of claim 8, wherein the enzyme is a Taq polymerase or a Thermosequenase.
- The method of any one of claims 1-4, wherein the probes are synthesised in situ.
- The method of any one of claims 1-4, wherein the probes are presynthesised.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9507238.5A GB9507238D0 (en) | 1995-04-07 | 1995-04-07 | Detecting dna sequence variations |
EP96909255A EP0820524B1 (en) | 1995-04-07 | 1996-04-09 | Detecting dna sequence variations |
EP03075104A EP1308523B1 (en) | 1995-04-07 | 1996-04-09 | Detecting DNA sequence variations |
Related Parent Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03075104A Division EP1308523B1 (en) | 1995-04-07 | 1996-04-09 | Detecting DNA sequence variations |
EP96909255.0 Division | 1996-10-10 | ||
EP03075104.4 Division | 2003-01-08 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1693469A2 EP1693469A2 (en) | 2006-08-23 |
EP1693469A3 EP1693469A3 (en) | 2007-07-04 |
EP1693469B1 true EP1693469B1 (en) | 2010-08-25 |
Family
ID=10772698
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03075104A Expired - Lifetime EP1308523B1 (en) | 1995-04-07 | 1996-04-09 | Detecting DNA sequence variations |
EP06076004A Expired - Lifetime EP1693469B1 (en) | 1995-04-07 | 1996-04-09 | Detecting DNA sequence variations |
EP96909255A Expired - Lifetime EP0820524B1 (en) | 1995-04-07 | 1996-04-09 | Detecting dna sequence variations |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03075104A Expired - Lifetime EP1308523B1 (en) | 1995-04-07 | 1996-04-09 | Detecting DNA sequence variations |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96909255A Expired - Lifetime EP0820524B1 (en) | 1995-04-07 | 1996-04-09 | Detecting dna sequence variations |
Country Status (6)
Country | Link |
---|---|
US (5) | US6150095A (en) |
EP (3) | EP1308523B1 (en) |
JP (3) | JP3908784B2 (en) |
DE (3) | DE69636843T2 (en) |
GB (1) | GB9507238D0 (en) |
WO (1) | WO1996031622A1 (en) |
Families Citing this family (197)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6270961B1 (en) * | 1987-04-01 | 2001-08-07 | Hyseq, Inc. | Methods and apparatus for DNA sequencing and DNA identification |
US6401267B1 (en) | 1993-09-27 | 2002-06-11 | Radoje Drmanac | Methods and compositions for efficient nucleic acid sequencing |
US7582421B2 (en) * | 1993-11-01 | 2009-09-01 | Nanogen, Inc. | Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip |
US6468742B2 (en) | 1993-11-01 | 2002-10-22 | Nanogen, Inc. | Methods for determination of single nucleic acid polymorphisms using bioelectronic microchip |
US6207373B1 (en) | 1998-02-25 | 2001-03-27 | Nanogen, Inc. | Methods for determining nature of repeat units in DNA |
AU1428097A (en) * | 1996-01-12 | 1997-08-01 | Hybridon, Inc. | Method of monitoring pharmacokinetics of oligonucleotide pharmaceuticals |
ES2288760T3 (en) | 1996-04-25 | 2008-01-16 | Bioarray Solutions Ltd. | ELECTROCINETIC ASSEMBLY CONTROLLED BY LIGHT OF PARTICLES NEXT TO SURFACES. |
GB9624165D0 (en) | 1996-11-19 | 1997-01-08 | Amdex A S | Use of nucleic acids bound to carrier macromolecules |
WO1998023776A1 (en) * | 1996-11-29 | 1998-06-04 | Amersham Pharmacia Biotech Uk Ltd. | Method for determining tandem repeat sequence length |
AUPO427996A0 (en) * | 1996-12-20 | 1997-01-23 | Co-Operative Research Centre For Diagnostic Technologies | Method for detecting a nucleotide at a specific location within a polynucleotide sequence and apparatus therefor |
US6309824B1 (en) * | 1997-01-16 | 2001-10-30 | Hyseq, Inc. | Methods for analyzing a target nucleic acid using immobilized heterogeneous mixtures of oligonucleotide probes |
US6297006B1 (en) * | 1997-01-16 | 2001-10-02 | Hyseq, Inc. | Methods for sequencing repetitive sequences and for determining the order of sequence subfragments |
US6309829B1 (en) | 1997-05-27 | 2001-10-30 | Pe Corporation (Ny) | Length determination of nucleic acid repeat sequences by discontinuous primer extension |
CN1264319A (en) | 1997-07-22 | 2000-08-23 | 拉普吉恩公司 | Apparatus and methods for arraying solution onto solid support |
AU729134B2 (en) * | 1997-07-22 | 2001-01-25 | Qiagen Genomics, Inc. | Amplification and other enzymatic reactions performed on nucleic acid arrays |
EP1003910A1 (en) * | 1997-07-22 | 2000-05-31 | Rapigene, Inc. | Multiple functionalities within an array element and uses thereof |
DE69839734D1 (en) * | 1997-12-22 | 2008-08-28 | Hitachi Chemical Co Ltd | Direct RT-PCR on microtiter plates with immobilized oligonucleotide |
US6844158B1 (en) | 1997-12-22 | 2005-01-18 | Hitachi Chemical Co., Ltd. | Direct RT-PCR on oligonucleotide-immobilized PCR microplates |
US6087102A (en) | 1998-01-07 | 2000-07-11 | Clontech Laboratories, Inc. | Polymeric arrays and methods for their use in binding assays |
US6289229B1 (en) | 1998-01-20 | 2001-09-11 | Scimed Life Systems, Inc. | Readable probe array for in vivo use |
US6355419B1 (en) | 1998-04-27 | 2002-03-12 | Hyseq, Inc. | Preparation of pools of nucleic acids based on representation in a sample |
EP2287338B1 (en) * | 1998-11-09 | 2012-09-05 | Eiken Kagaku Kabushiki Kaisha | Process for synthesizing nucleic acid |
US6410231B1 (en) | 1999-02-26 | 2002-06-25 | Incyte Genomics, Inc. | SNP detection |
EP1159453B1 (en) * | 1999-03-10 | 2008-05-28 | ASM Scientific, Inc. | A method for direct nucleic acid sequencing |
CN1192116C (en) * | 1999-03-30 | 2005-03-09 | 内诺金有限公司 | Single nucleotide polymorphic discrimination by electronic dot blot assay on semiconductor microchips |
DE60014350T2 (en) * | 1999-04-09 | 2005-10-13 | Keygene N.V. | METHOD OF DETECTION AND / OR ANALYSIS, USING PRIMER TECHNIQUES, OF SIMPLE NUCLEOTIDE POLYMORPHISMS IN RESTRICTION FRAGMENTS SPECIALLY MADE FROM AMPLIFIED RESTRICTION FRAGMENTS GENERATED BY AFLP |
EP1923472B1 (en) * | 1999-04-20 | 2012-04-11 | Illumina, Inc. | Detection of nucleic acid reactions on bead arrays |
US20060275782A1 (en) | 1999-04-20 | 2006-12-07 | Illumina, Inc. | Detection of nucleic acid reactions on bead arrays |
EP1171637A2 (en) * | 1999-04-27 | 2002-01-16 | The University Of Chicago | Nucleotide extension on a microarray of gel-immobilized primers |
MXPA02002163A (en) * | 1999-09-01 | 2004-04-21 | Yeda Res & Dev | Template-dependent nucleic acid polymerization using oligonucleotide triphosphates building blocks. |
US7244559B2 (en) | 1999-09-16 | 2007-07-17 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
US7211390B2 (en) | 1999-09-16 | 2007-05-01 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
US6297016B1 (en) | 1999-10-08 | 2001-10-02 | Applera Corporation | Template-dependent ligation with PNA-DNA chimeric probes |
US6500620B2 (en) | 1999-12-29 | 2002-12-31 | Mergen Ltd. | Methods for amplifying and detecting multiple polynucleotides on a solid phase support |
US7582420B2 (en) | 2001-07-12 | 2009-09-01 | Illumina, Inc. | Multiplex nucleic acid reactions |
US6376191B1 (en) * | 2000-03-22 | 2002-04-23 | Mergen, Ltd. | Microarray-based analysis of polynucleotide sequence variations |
US7829313B2 (en) | 2000-03-24 | 2010-11-09 | Eppendorf Array Technologies | Identification and quantification of a plurality of biological (micro)organisms or their components |
US7875442B2 (en) | 2000-03-24 | 2011-01-25 | Eppendorf Array Technologies | Identification and quantification of a plurality of biological (micro)organisms or their components |
EP1349954B1 (en) | 2000-05-19 | 2011-01-26 | Eragen Biosciences, Inc. | Materials and methods for detection of nucleic acids |
ES2259666T3 (en) | 2000-06-21 | 2006-10-16 | Bioarray Solutions Ltd | MOLECULAR ANALYSIS OF MULTIPLE ANALYTICS USING SERIES OF RANDOM PARTICLES WITH APPLICATION SPECIFICITY. |
US9709559B2 (en) | 2000-06-21 | 2017-07-18 | Bioarray Solutions, Ltd. | Multianalyte molecular analysis using application-specific random particle arrays |
JP4310599B2 (en) * | 2000-07-05 | 2009-08-12 | 東洋紡績株式会社 | Method for detecting nucleotide polymorphisms |
EP1180548B1 (en) * | 2000-07-31 | 2005-11-02 | Agilent Technologies, Inc. (a Delaware corporation) | Array based methods for synthesizing nucleic acid mixtures |
ATE316581T1 (en) | 2000-09-05 | 2006-02-15 | Zeltz Patrick Dr | METHOD FOR THE SPECIFIC DETERMINATION OF DNA SEQUENCES USING PARALLEL AMPLIFICATION |
AU1317502A (en) | 2000-10-14 | 2002-04-29 | Eragen Biosciences Inc | Solid support assay systems and methods utilizing non-standard bases |
CN100385013C (en) * | 2000-10-14 | 2008-04-30 | 伊拉根生物科学公司 | Solid support assay systems and methods utilizing non-standard bases |
EP1349924A2 (en) | 2000-11-03 | 2003-10-08 | Dana Farber Cancer Institute | Methods and compositions for the diagnosis of cancer susceptibilites and defective dna repair mechanisms and treatment thereof |
US6489115B2 (en) * | 2000-12-21 | 2002-12-03 | The Board Of Regents Of The University Of Nebraska | Genetic assays for trinucleotide repeat mutations in eukaryotic cells |
US7226737B2 (en) * | 2001-01-25 | 2007-06-05 | Luminex Molecular Diagnostics, Inc. | Polynucleotides for use as tags and tag complements, manufacture and use thereof |
JP4588976B2 (en) * | 2001-01-25 | 2010-12-01 | ルミネックス モレキュラー ダイアグノスティックス, インク. | Polynucleotides, products, and uses thereof as tags and tag complements |
US20030165865A1 (en) * | 2001-01-29 | 2003-09-04 | Hinkel Christopher A. | Methods of analysis of nucleic acids |
WO2002079518A1 (en) * | 2001-03-29 | 2002-10-10 | Chugai Seiyaku Kabushiki Kaisha | A method for genotyping individuals for multiple snps |
US6986992B2 (en) * | 2001-03-30 | 2006-01-17 | Amersham Biosciences Ab | P450 single nucleotide polymorphism biochip analysis |
EP1256632A3 (en) * | 2001-05-07 | 2004-01-02 | Smithkline Beecham Corporation | High throughput polymorphism screening |
EP1423530A2 (en) * | 2001-05-18 | 2004-06-02 | Azign Bioscience A/S | G-protein coupled receptor arrays |
JP2002372533A (en) * | 2001-06-13 | 2002-12-26 | Kiwamu Akagi | Examination method of blood, examination chip, and examination device |
US7262063B2 (en) | 2001-06-21 | 2007-08-28 | Bio Array Solutions, Ltd. | Directed assembly of functional heterostructures |
EP1402070B1 (en) | 2001-06-27 | 2012-01-11 | Cancer Research Technology Limited | Methods for the diagnosis of cancer based on the obcam and ntm genes |
US20030082584A1 (en) * | 2001-06-29 | 2003-05-01 | Liang Shi | Enzymatic ligation-based identification of transcript expression |
US20030170695A1 (en) * | 2001-06-29 | 2003-09-11 | Liang Shi | Enzymatic ligation-based identification of nucleotide sequences |
US20050009022A1 (en) * | 2001-07-06 | 2005-01-13 | Weiner Michael P. | Method for isolation of independent, parallel chemical micro-reactions using a porous filter |
US20030054396A1 (en) * | 2001-09-07 | 2003-03-20 | Weiner Michael P. | Enzymatic light amplification |
US20080138800A1 (en) * | 2001-10-15 | 2008-06-12 | Alice Xiang Li | Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection |
EP2722395B1 (en) * | 2001-10-15 | 2018-12-19 | Bioarray Solutions Ltd | Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection |
US6956114B2 (en) | 2001-10-30 | 2005-10-18 | '454 Corporation | Sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
US20050124022A1 (en) * | 2001-10-30 | 2005-06-09 | Maithreyan Srinivasan | Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
US6902921B2 (en) * | 2001-10-30 | 2005-06-07 | 454 Corporation | Sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
US7294504B1 (en) * | 2001-12-27 | 2007-11-13 | Allele Biotechnology & Pharmaceuticals, Inc. | Methods and compositions for DNA mediated gene silencing |
AU2003220254B2 (en) | 2002-03-13 | 2008-09-18 | Syngenta Participations, Ag. | Nucleic acid detection method |
US9126165B1 (en) | 2002-04-24 | 2015-09-08 | The University Of North Carolina At Greensboro | Nucleic acid arrays to monitor water and other ecosystems |
US8048623B1 (en) | 2002-04-24 | 2011-11-01 | The University Of North Carolina At Greensboro | Compositions, products, methods and systems to monitor water and other ecosystems |
US8383342B2 (en) | 2002-04-24 | 2013-02-26 | The University Of North Carolina At Greensboro | Compositions, products, methods and systems to monitor water and other ecosystems |
US7214492B1 (en) | 2002-04-24 | 2007-05-08 | The University Of North Carolina At Greensboro | Nucleic acid arrays to monitor water and other ecosystems |
US7601493B2 (en) * | 2002-07-26 | 2009-10-13 | Nanogen, Inc. | Methods and apparatus for screening and detecting multiple genetic mutations |
WO2004011646A1 (en) | 2002-07-30 | 2004-02-05 | Tum Gene,Inc. | Method of detecting base mutation |
WO2004020654A2 (en) * | 2002-08-30 | 2004-03-11 | Bayer Healthcare Llc | Solid phase based nucleic acid assays combining high affinity and high specificity |
US7157228B2 (en) * | 2002-09-09 | 2007-01-02 | Bioarray Solutions Ltd. | Genetic analysis and authentication |
WO2004047007A1 (en) | 2002-11-15 | 2004-06-03 | Bioarray Solutions, Ltd. | Analysis, secure access to, and transmission of array images |
EP1590482B1 (en) | 2003-01-17 | 2008-12-10 | Eragen Biosciences, Inc. | Nucleic acid amplification using non-standard bases |
US7575865B2 (en) * | 2003-01-29 | 2009-08-18 | 454 Life Sciences Corporation | Methods of amplifying and sequencing nucleic acids |
AU2004254552B2 (en) | 2003-01-29 | 2008-04-24 | 454 Life Sciences Corporation | Methods of amplifying and sequencing nucleic acids |
CA2458085A1 (en) | 2003-03-21 | 2004-09-21 | F. Hoffmann-La Roche Ag | Transcriptional activity assay |
AU2004227353B2 (en) | 2003-04-01 | 2010-02-25 | Luminex Corporation | Polymerase inhibitor and method of using same |
US20050233390A1 (en) * | 2003-04-09 | 2005-10-20 | Allen John W | Device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor |
AU2003902299A0 (en) * | 2003-05-13 | 2003-05-29 | Flinders Medical Centre | A method of analysing a marker nucleic acid molecule |
DE10325098B3 (en) * | 2003-06-03 | 2004-12-02 | IPK-Institut für Pflanzengenetik und Kulturpflanzenforschung | Procedure for SNP analysis on biochips with oligonucleotide areas |
US20050181394A1 (en) * | 2003-06-20 | 2005-08-18 | Illumina, Inc. | Methods and compositions for whole genome amplification and genotyping |
US7670810B2 (en) | 2003-06-20 | 2010-03-02 | Illumina, Inc. | Methods and compositions for whole genome amplification and genotyping |
US20040259100A1 (en) * | 2003-06-20 | 2004-12-23 | Illumina, Inc. | Methods and compositions for whole genome amplification and genotyping |
AU2004254636A1 (en) * | 2003-07-02 | 2005-01-13 | Perkinelmer Las, Inc. | Assay and process for labeling and detection of micro RNA and small interfering RNA sequences |
WO2005029705A2 (en) | 2003-09-18 | 2005-03-31 | Bioarray Solutions, Ltd. | Number coding for identification of subtypes of coded types of solid phase carriers |
ES2375962T3 (en) | 2003-09-22 | 2012-03-07 | Bioarray Solutions Ltd | IMMOBILIZED SURFACE POLYELECTROLYTE WITH MULTIPLE FUNCTIONAL GROUPS ABLE TO JOIN COVALENTLY TO BIOMOLECULES. |
EP1692298A4 (en) | 2003-10-28 | 2008-08-13 | Bioarray Solutions Ltd | Optimization of gene expression analysis using immobilized capture probes |
ES2533876T3 (en) | 2003-10-29 | 2015-04-15 | Bioarray Solutions Ltd | Multiplexed nucleic acid analysis by double stranded DNA fragmentation |
WO2005118862A2 (en) * | 2004-04-30 | 2005-12-15 | Applera Corporation | Compositions, methods, and kits for (mis)ligating oligonucleotides |
US20060008823A1 (en) * | 2004-05-12 | 2006-01-12 | Kemp Jennifer T | DNA profiling and SNP detection utilizing microarrays |
EP2471921A1 (en) | 2004-05-28 | 2012-07-04 | Asuragen, Inc. | Methods and compositions involving microRNA |
US7848889B2 (en) | 2004-08-02 | 2010-12-07 | Bioarray Solutions, Ltd. | Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification |
US7238486B2 (en) * | 2004-09-21 | 2007-07-03 | The Board Of Trustees Of The Leland Stanford Junior University | DNA fingerprinting using a branch migration assay |
US7501253B2 (en) * | 2004-09-21 | 2009-03-10 | The Board Of Trustees Of The Leland Stanford Junior University | DNA fingerprinting using a branch migration assay |
EP2302054B1 (en) | 2004-11-12 | 2014-07-16 | Asuragen, Inc. | Methods and compositions involving miRNA and miRNA inhibitor molecules |
US7977119B2 (en) * | 2004-12-08 | 2011-07-12 | Agilent Technologies, Inc. | Chemical arrays and methods of using the same |
EP1869213A4 (en) | 2005-03-14 | 2008-05-14 | Univ Leland Stanford Junior | Methods and compositions for evaluating graft survival in a solid organ transplant recipient |
WO2006101913A2 (en) | 2005-03-18 | 2006-09-28 | Eragen Biosciences, Inc. | Methods for detecting multiple species and subspecies of neiserria |
US20060240443A1 (en) * | 2005-04-20 | 2006-10-26 | Combimatrix Corporation | Microarray-based single nucleotide polymorphism, sequencing, and gene expression assay method |
US8486629B2 (en) | 2005-06-01 | 2013-07-16 | Bioarray Solutions, Ltd. | Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation |
WO2006133184A2 (en) | 2005-06-07 | 2006-12-14 | Eragen Biosciences, Inc. | Methods for detection and typing of nucleic acids |
EP1731620A1 (en) | 2005-06-07 | 2006-12-13 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Method for the diagnosis of immune graft tolerance |
WO2007021502A1 (en) * | 2005-08-10 | 2007-02-22 | Ge Healthcare Bio-Sciences Corp. | Quality control methods for arrayed oligonucleotides |
US7359222B2 (en) * | 2005-09-15 | 2008-04-15 | Power Integrations, Inc. | Method and apparatus to improve regulation of a power supply |
US20070065860A1 (en) * | 2005-09-20 | 2007-03-22 | Hildebrand William H | Accelerated class I and class II HLA DNA sequence-based typing |
DE602006013511D1 (en) | 2005-12-29 | 2010-05-20 | Ind Cooperation Agency | ONE STEP DIAGNOSIS WITH DNA CHIP |
US8841069B2 (en) | 2005-12-29 | 2014-09-23 | Korea Materials & Analysis Corporation | Dendron-mediated DNA virus detection |
US20070196832A1 (en) * | 2006-02-22 | 2007-08-23 | Efcavitch J William | Methods for mutation detection |
JP2007267644A (en) * | 2006-03-30 | 2007-10-18 | Toshiba Corp | Method for measuring number of recurrence of unit base |
CA2657576C (en) | 2006-07-14 | 2023-10-31 | The Regents Of The University Of California | Cancer biomarkers and methods of use thereof |
CA2663962A1 (en) | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Mir-15, mir-26, mir-31,mir-145, mir-147, mir-188, mir-215, mir-216, mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention |
WO2008036765A2 (en) | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Micrornas differentially expressed in pancreatic diseases and uses thereof |
US9845494B2 (en) * | 2006-10-18 | 2017-12-19 | Affymetrix, Inc. | Enzymatic methods for genotyping on arrays |
JP5670055B2 (en) | 2007-01-30 | 2015-02-18 | ファーマサイクリックス,インク. | Methods for determining cancer resistance to histone deacetylase inhibitors |
US20080194416A1 (en) * | 2007-02-08 | 2008-08-14 | Sigma Aldrich | Detection of mature small rna molecules |
JP5266646B2 (en) * | 2007-02-15 | 2013-08-21 | 東レ株式会社 | Method for measuring the number of sequences of repeated base sequences and kit for measuring the number of sequences of repeated base sequences |
EP1961825A1 (en) | 2007-02-26 | 2008-08-27 | INSERM (Institut National de la Santé et de la Recherche Medicale) | Method for predicting the occurrence of metastasis in breast cancer patients |
WO2009031054A2 (en) * | 2007-06-29 | 2009-03-12 | Population Genetics Technologies Ltd. | Methods and compositions for isolating nucleic acid sequence variants |
JP2009011247A (en) * | 2007-07-05 | 2009-01-22 | Sumitomo Bakelite Co Ltd | Method for detecting gene |
US20090061424A1 (en) * | 2007-08-30 | 2009-03-05 | Sigma-Aldrich Company | Universal ligation array for analyzing gene expression or genomic variations |
US8658379B2 (en) | 2008-01-29 | 2014-02-25 | University of Pittsburgh—of the Commonwealth System of Higher Education | Follistatin-like protein-1 as a biomarker for sepsis |
US8211652B2 (en) | 2008-01-29 | 2012-07-03 | University of Pittsburgh—of the Commonwealth System of Higher Education | FSTL-1 as a biomaker of inflammation |
EP2113574A1 (en) | 2008-04-28 | 2009-11-04 | Biotype AG | Substances and methods for a DNA based profiling assay |
WO2009137807A2 (en) | 2008-05-08 | 2009-11-12 | Asuragen, Inc. | Compositions and methods related to mirna modulation of neovascularization or angiogenesis |
US20110201519A1 (en) | 2008-08-18 | 2011-08-18 | Sarwal Minnie M | Methods and Compositions for Determining a Graft Tolerant Phenotype in a Subject |
ES2399711T3 (en) | 2009-08-22 | 2013-04-02 | The Board Of Trustees Of The University Of The Leland Stanford Junior University | Obtaining images and evaluation of embryos, oocytes and stem cells |
US8975019B2 (en) * | 2009-10-19 | 2015-03-10 | University Of Massachusetts | Deducing exon connectivity by RNA-templated DNA ligation/sequencing |
US9644240B2 (en) | 2009-10-22 | 2017-05-09 | Leiden University | Disease susceptibility |
EP2314714A1 (en) | 2009-10-22 | 2011-04-27 | Universiteit Leiden | Disease susceptibility |
US8440406B2 (en) | 2009-10-23 | 2013-05-14 | Luminex Corporation | Amplification primers with non-standard bases for increased reaction specificity |
US9290813B2 (en) | 2009-12-02 | 2016-03-22 | The Board Of Trustees Of The Leland Stanford Junior University | Biomarkers for determining an allograft tolerant phenotype |
GB0922085D0 (en) | 2009-12-17 | 2010-02-03 | Cambridge Entpr Ltd | Cancer diagnosis and treatment |
WO2011109398A2 (en) | 2010-03-02 | 2011-09-09 | President And Fellows Of Harvard College | Methods and compositions for treatment of angelman syndrome and autism spectrum disorders |
WO2011108930A1 (en) | 2010-03-04 | 2011-09-09 | Interna Technologies Bv | A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT |
EP2561092A1 (en) | 2010-04-19 | 2013-02-27 | The Procter & Gamble Company | Genetic signatures and gene chips associated with administration of electrically conducted radio frequency current to skin and methods and treatments relating thereto |
BR112012026871A2 (en) | 2010-04-19 | 2017-06-06 | Procter & Gamble | combined application of topical composition and energy to regulate mammalian skin condition |
EP3508854A1 (en) | 2010-04-27 | 2019-07-10 | The Regents of The University of California | Cancer biomarkers and methods of use thereof |
NZ719520A (en) | 2010-07-06 | 2017-07-28 | Int Tech Bv | Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway |
WO2012019099A2 (en) | 2010-08-05 | 2012-02-09 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Follistatin-like-protein-1 as a biomarker for inflammatory disorders |
SG188397A1 (en) | 2010-09-15 | 2013-04-30 | Almac Diagnostics Ltd | Molecular diagnostic test for cancer |
ES2629890T3 (en) | 2010-11-17 | 2017-08-16 | Interpace Diagnostics, Llc | miRNA as biomarkers to distinguish between benign and malignant thyroid neoplasms |
EP2474617A1 (en) | 2011-01-11 | 2012-07-11 | InteRNA Technologies BV | Mir for treating neo-angiogenesis |
WO2012116185A1 (en) | 2011-02-23 | 2012-08-30 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of detecting aneuploidy in human embryos |
WO2012158238A2 (en) | 2011-02-28 | 2012-11-22 | University Of Iowa Research Foundation | Anti-müllerian hormone changes in pregnancy and prediction ofadverse pregnancy outcomes and gender |
EP2715348B1 (en) | 2011-06-02 | 2019-04-10 | Almac Diagnostic Services Limited | Molecular diagnostic test for cancer |
JP2014527036A (en) | 2011-06-27 | 2014-10-09 | ザ ジャクソン ラボラトリー | Methods and compositions for the treatment of cancer and autoimmune diseases |
WO2013009705A2 (en) | 2011-07-09 | 2013-01-17 | The Trustees Of Columbia University In The City Of New York | Biomarkers, methods, and compositions for inhibiting a multi-cancer mesenchymal transition mechanism |
WO2013040251A2 (en) | 2011-09-13 | 2013-03-21 | Asurgen, Inc. | Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease |
WO2013063519A1 (en) | 2011-10-26 | 2013-05-02 | Asuragen, Inc. | Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts |
US20130142728A1 (en) | 2011-10-27 | 2013-06-06 | Asuragen, Inc. | Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors |
WO2013087789A1 (en) | 2011-12-13 | 2013-06-20 | Glykos Finland Ltd. | Antibody isoform arrays and methods thereof |
CN104136611B (en) * | 2012-02-27 | 2018-03-27 | 东丽株式会社 | The detection method of nucleic acid |
EP2870263A1 (en) | 2012-07-03 | 2015-05-13 | InteRNA Technologies B.V. | Diagnostic portfolio and its uses |
US20140100124A1 (en) | 2012-10-04 | 2014-04-10 | Asuragen, Inc. | Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions |
MX2015006955A (en) | 2012-12-03 | 2016-01-25 | Almac Diagnostics Ltd | Molecular diagnostic test for cancer. |
EP2970909A4 (en) | 2013-03-15 | 2017-02-15 | The University of Chicago | Methods and compositions related to t-cell activity |
WO2014151551A1 (en) | 2013-03-15 | 2014-09-25 | Baylor Research Institute | Ulcerative colitis (uc)-associated colorectal neoplasia markers |
EP2971132B1 (en) | 2013-03-15 | 2020-05-06 | Baylor Research Institute | Tissue and blood-based mirna biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer |
JP6427883B2 (en) * | 2014-01-27 | 2018-11-28 | 株式会社大林組 | Finishing method of cement composition |
GB201409479D0 (en) | 2014-05-28 | 2014-07-09 | Almac Diagnostics Ltd | Molecular diagnostic test for cancer |
WO2016025510A1 (en) | 2014-08-12 | 2016-02-18 | Rappolee Daniel A | Systems and methods to detect stem cell stress and uses thereof |
US11543411B2 (en) | 2014-12-05 | 2023-01-03 | Prelude Corporation | DCIS recurrence and invasive breast cancer |
TW201702218A (en) | 2014-12-12 | 2017-01-16 | 美國杰克森實驗室 | Compositions and methods relating to the treatment of cancer, autoimmune disease, and neurodegenerative disease |
GB201512869D0 (en) | 2015-07-21 | 2015-09-02 | Almac Diagnostics Ltd | Gene signature for minute therapies |
GB2563357A (en) * | 2016-02-10 | 2018-12-12 | Nec Corp | DNA testing chip, DNA testing method, DNA testing system, and DNA testing chip control device |
WO2017181367A1 (en) | 2016-04-20 | 2017-10-26 | Ldx Prognostics Limited Co. | Methods and compositions for prognosing preterm birth |
CN109196362A (en) | 2016-05-17 | 2019-01-11 | 苏州爱尔迪思生物科技有限公司 | For providing the method and composition of preeclampsia assessment |
US9932631B1 (en) | 2017-09-11 | 2018-04-03 | Omniome, Inc. | Genotyping by polymerase binding |
WO2018136117A1 (en) | 2017-01-20 | 2018-07-26 | Omniome, Inc. | Allele-specific capture of nucleic acids |
KR20200105808A (en) | 2017-09-11 | 2020-09-09 | 사이티어 테라퓨틱스, 인크. | RAD51 inhibitor |
US11497762B2 (en) | 2017-11-03 | 2022-11-15 | Interna Technologies B.V. | MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation |
WO2019213660A2 (en) | 2018-05-04 | 2019-11-07 | The Broad Institute, Inc. | Compositions and methods for modulating cgrp signaling to regulate innate lymphoid cell inflammatory responses |
EP3837380A4 (en) | 2018-08-17 | 2022-05-11 | Cellecta, Inc. | Multiplex preparation of barcoded gene specific dna fragments |
WO2020056338A1 (en) | 2018-09-14 | 2020-03-19 | Prelude Corporation | Method of selection for treatment of subjects at risk of invasive breast cancer |
US20220401460A1 (en) | 2018-10-10 | 2022-12-22 | Dana-Farber Cancer Institute, Inc. | Modulating resistance to bcl-2 inhibitors |
AU2020228047A1 (en) | 2019-02-27 | 2021-09-30 | Madera Therapeutics, LLC | Use of caseinolytic protease P function as a biomarker of drug response to imipridone-like agents |
MX2021010916A (en) | 2019-03-12 | 2021-10-01 | Cyteir Therapeutics Inc | Rad51 inhibitors. |
US20220154282A1 (en) | 2019-03-12 | 2022-05-19 | The Broad Institute, Inc. | Detection means, compositions and methods for modulating synovial sarcoma cells |
US20220143148A1 (en) | 2019-03-14 | 2022-05-12 | The Broad Institute, Inc. | Compositions and methods for modulating cgrp signaling to regulate intestinal innate lymphoid cells |
US20220142948A1 (en) | 2019-03-18 | 2022-05-12 | The Broad Institute, Inc. | Compositions and methods for modulating metabolic regulators of t cell pathogenicity |
WO2020191069A1 (en) | 2019-03-18 | 2020-09-24 | The Broad Institute, Inc. | Modulation of type 2 immunity by targeting clec-2 signaling |
KR20210143257A (en) | 2019-03-25 | 2021-11-26 | 사이티어 테라퓨틱스, 인크. | Combination of RAD51 inhibitor and PARP inhibitor |
KR20210151944A (en) | 2019-04-12 | 2021-12-14 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | Compositions and methods for increasing muscle mass and oxidative metabolism |
KR20220024857A (en) | 2019-06-21 | 2022-03-03 | 사이티어 테라퓨틱스, 인크. | Methods of use of RAD51 inhibitors for the treatment of pancreatic cancer |
US20220282333A1 (en) | 2019-08-13 | 2022-09-08 | The General Hospital Corporation | Methods for predicting outcomes of checkpoint inhibition and treatment thereof |
US11793787B2 (en) | 2019-10-07 | 2023-10-24 | The Broad Institute, Inc. | Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis |
US11844800B2 (en) | 2019-10-30 | 2023-12-19 | Massachusetts Institute Of Technology | Methods and compositions for predicting and preventing relapse of acute lymphoblastic leukemia |
US20230044602A1 (en) | 2019-12-20 | 2023-02-09 | EDWARD Via COLLEGE OF OSTEOPATHIC MEDICINE | Cancer signatures, methods of generating cancer signatures, and uses thereof |
KR20220149733A (en) | 2020-03-03 | 2022-11-08 | 사이티어 테라퓨틱스, 인크. | RAD51 Inhibitor Compound 67A (2301085-06-1) at a Specific Dosage to Treat Cancer |
WO2022192419A2 (en) | 2021-03-09 | 2022-09-15 | Massachusetts Institute Of Technology | Methods of treating inflammatory bowel disease (ibd) with anti- tnf-blockade |
WO2024028794A1 (en) | 2022-08-02 | 2024-02-08 | Temple Therapeutics BV | Methods for treating endometrial and ovarian hyperproliferative disorders |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4883750A (en) * | 1984-12-13 | 1989-11-28 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
US4797355A (en) * | 1985-06-13 | 1989-01-10 | Amgen Inc. | Methods for attaching polynucleotides to supports |
US4851331A (en) * | 1986-05-16 | 1989-07-25 | Allied Corporation | Method and kit for polynucleotide assay including primer-dependant DNA polymerase |
GB8612087D0 (en) * | 1986-05-19 | 1986-06-25 | Ici Plc | Hybridisation probes |
US5403711A (en) * | 1987-11-30 | 1995-04-04 | University Of Iowa Research Foundation | Nucleic acid hybridization and amplification method for detection of specific sequences in which a complementary labeled nucleic acid probe is cleaved |
GB8810400D0 (en) | 1988-05-03 | 1988-06-08 | Southern E | Analysing polynucleotide sequences |
US5700637A (en) * | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
CA2044591C (en) | 1989-02-13 | 2002-08-13 | James Langham Dale | Detection of a nucleic acid sequence or a change therein |
US5856092A (en) * | 1989-02-13 | 1999-01-05 | Geneco Pty Ltd | Detection of a nucleic acid sequence or a change therein |
US6013431A (en) | 1990-02-16 | 2000-01-11 | Molecular Tool, Inc. | Method for determining specific nucleotide variations by primer extension in the presence of mixture of labeled nucleotides and terminators |
IL97222A (en) | 1990-02-16 | 1995-08-31 | Orion Yhtymae Oy | Method and reagent for determining specific nucleotide variations |
US6004744A (en) * | 1991-03-05 | 1999-12-21 | Molecular Tool, Inc. | Method for determining nucleotide identity through extension of immobilized primer |
US5888819A (en) * | 1991-03-05 | 1999-03-30 | Molecular Tool, Inc. | Method for determining nucleotide identity through primer extension |
US5348853A (en) * | 1991-12-16 | 1994-09-20 | Biotronics Corporation | Method for reducing non-specific priming in DNA amplification |
NZ245242A (en) * | 1992-01-17 | 1994-12-22 | Pioneer Hi Bred Int | Identifying variations between organisms by detecting polymorphisms in single sequence repeats |
US5981176A (en) * | 1992-06-17 | 1999-11-09 | City Of Hope | Method of detecting and discriminating between nucleic acid sequences |
CA2115342C (en) * | 1992-06-17 | 2003-08-26 | Robert B. Wallace | A method of detecting and discriminating between nucleic acid sequences |
US5795714A (en) * | 1992-11-06 | 1998-08-18 | Trustees Of Boston University | Method for replicating an array of nucleic acid probes |
SE501439C2 (en) | 1993-06-22 | 1995-02-13 | Pharmacia Lkb Biotech | Method and apparatus for analyzing polynucleotide sequences |
US5858659A (en) * | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
GB9315847D0 (en) * | 1993-07-30 | 1993-09-15 | Isis Innovation | Tag reagent and assay method |
DE69433487T2 (en) * | 1993-09-27 | 2004-11-25 | Arch Development Corp., Chicago | METHODS AND COMPOSITIONS FOR EFFICIENT NUCLEIC ACID SEQUENCING |
US6156501A (en) * | 1993-10-26 | 2000-12-05 | Affymetrix, Inc. | Arrays of modified nucleic acid probes and methods of use |
EP0754240B1 (en) * | 1994-02-07 | 2003-08-20 | Beckman Coulter, Inc. | Ligase/polymerase-mediated genetic bit analysis of single nucleotide polymorphisms and its use in genetic analysis |
WO1995027078A1 (en) * | 1994-04-04 | 1995-10-12 | Ciba Corning Diagnostics Corp. | Hibridization-ligation assays for the detection of specific nucleic acid sequences |
US6974666B1 (en) * | 1994-10-21 | 2005-12-13 | Appymetric, Inc. | Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA |
US5759779A (en) * | 1995-08-29 | 1998-06-02 | Dehlinger; Peter J. | Polynucleotide-array assay and methods |
US5723320A (en) * | 1995-08-29 | 1998-03-03 | Dehlinger; Peter J. | Position-addressable polynucleotide arrays |
US6023540A (en) * | 1997-03-14 | 2000-02-08 | Trustees Of Tufts College | Fiber optic sensor with encoded microspheres |
US6355431B1 (en) * | 1999-04-20 | 2002-03-12 | Illumina, Inc. | Detection of nucleic acid amplification reactions using bead arrays |
-
1995
- 1995-04-07 GB GBGB9507238.5A patent/GB9507238D0/en active Pending
-
1996
- 1996-04-09 DE DE69636843T patent/DE69636843T2/en not_active Expired - Lifetime
- 1996-04-09 JP JP53011396A patent/JP3908784B2/en not_active Expired - Lifetime
- 1996-04-09 EP EP03075104A patent/EP1308523B1/en not_active Expired - Lifetime
- 1996-04-09 EP EP06076004A patent/EP1693469B1/en not_active Expired - Lifetime
- 1996-04-09 WO PCT/GB1996/000848 patent/WO1996031622A1/en active IP Right Grant
- 1996-04-09 EP EP96909255A patent/EP0820524B1/en not_active Expired - Lifetime
- 1996-04-09 DE DE69638248T patent/DE69638248D1/en not_active Expired - Lifetime
- 1996-04-09 US US08/930,798 patent/US6150095A/en not_active Expired - Lifetime
- 1996-04-09 DE DE69633974T patent/DE69633974T2/en not_active Expired - Lifetime
-
2000
- 2000-02-11 US US09/502,778 patent/US6307039B1/en not_active Expired - Lifetime
-
2001
- 2001-08-23 US US09/934,604 patent/US6770751B2/en not_active Expired - Lifetime
-
2003
- 2003-11-06 US US10/701,605 patent/US7192707B2/en not_active Expired - Fee Related
-
2006
- 2006-05-17 JP JP2006137603A patent/JP2006246897A/en active Pending
- 2006-09-07 US US11/516,521 patent/US8084211B2/en not_active Expired - Fee Related
-
2007
- 2007-08-22 JP JP2007216119A patent/JP2007306940A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1693469A3 (en) | 2007-07-04 |
US6770751B2 (en) | 2004-08-03 |
US6150095A (en) | 2000-11-21 |
GB9507238D0 (en) | 1995-05-31 |
JP3908784B2 (en) | 2007-04-25 |
US20050266408A1 (en) | 2005-12-01 |
DE69638248D1 (en) | 2010-10-07 |
US6307039B1 (en) | 2001-10-23 |
JP2006246897A (en) | 2006-09-21 |
US7192707B2 (en) | 2007-03-20 |
JPH11503019A (en) | 1999-03-23 |
EP1308523A2 (en) | 2003-05-07 |
US20020106665A1 (en) | 2002-08-08 |
DE69636843T2 (en) | 2007-10-18 |
US8084211B2 (en) | 2011-12-27 |
WO1996031622A1 (en) | 1996-10-10 |
DE69633974T2 (en) | 2005-12-01 |
EP1308523B1 (en) | 2007-01-10 |
DE69636843D1 (en) | 2007-02-22 |
DE69633974D1 (en) | 2005-01-05 |
EP1308523A3 (en) | 2003-12-10 |
EP0820524B1 (en) | 2004-12-01 |
EP1693469A2 (en) | 2006-08-23 |
JP2007306940A (en) | 2007-11-29 |
US20070111235A1 (en) | 2007-05-17 |
EP0820524A1 (en) | 1998-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1693469B1 (en) | Detecting DNA sequence variations | |
US6294336B1 (en) | Method for analyzing the nucleotide sequence of a polynucleotide by oligonucleotide extension on an array | |
US6972174B2 (en) | Method for detecting single nucleotide polymorphisms (SNP's) and point mutations | |
CN111032881B (en) | Accurate and large-scale parallel quantification of nucleic acids | |
Chetverin et al. | Oligonucleotide arrays: New concepts and possibilities | |
EP1138782B1 (en) | Multiplex sequence variation analysis of DNA samples by mass spectrometry | |
EP1609875B1 (en) | DNA typing with short tandem repeat polymorphisms and identification of polymorphic short tandem repeats | |
US6387626B1 (en) | Covalent attachment of unmodified nucleic acids to silanized solid phase surfaces | |
WO1998059066A1 (en) | Methods for the detection of multiple single nucleotide polymorphisms in a single reaction | |
JP2000510710A (en) | Immobilization of nucleic acid molecule to solid phase by disulfide bond by covalent bond | |
US6692915B1 (en) | Sequencing a polynucleotide on a generic chip | |
US6653070B1 (en) | Genomic analysis process and agent | |
JP2022549048A (en) | Methods and compositions for identifying ligands on arrays using indices and barcodes | |
JP2004024247A (en) | Probe for detecting gene variation and method for detecting the gene variation | |
Pastinen | Single nucleotide polymorphism genotyping using microarrays | |
JP5058160B2 (en) | Detection method of gene expression | |
Holton | SNP genotyping (zip code or apex methods), protein arrays and gene expression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AC | Divisional application: reference to earlier application |
Ref document number: 0820524 Country of ref document: EP Kind code of ref document: P Ref document number: 1308523 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): CH DE FR GB LI |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): CH DE FR GB LI |
|
17P | Request for examination filed |
Effective date: 20071218 |
|
17Q | First examination report despatched |
Effective date: 20080128 |
|
AKX | Designation fees paid |
Designated state(s): CH DE FR GB LI |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AC | Divisional application: reference to earlier application |
Ref document number: 1308523 Country of ref document: EP Kind code of ref document: P Ref document number: 0820524 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): CH DE FR GB LI |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REF | Corresponds to: |
Ref document number: 69638248 Country of ref document: DE Date of ref document: 20101007 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: PATENTANWAELTE SCHAAD, BALASS, MENZL & PARTNER AG |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20110526 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 69638248 Country of ref document: DE Effective date: 20110526 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20150423 Year of fee payment: 20 Ref country code: DE Payment date: 20150428 Year of fee payment: 20 Ref country code: CH Payment date: 20150423 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20150422 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 69638248 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20160408 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20160408 |